Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples
Verena Haselmann, Maximilian Kittel, Catharina Gerhards, et al.
Clinica Chimica Acta (2020) Vol. 510, pp. 73-78
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Yannick Galipeau, Matthew Greig, George Liu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 243
Antibody tests for identification of current and past infection with SARS-CoV-2
Tilly Fox, Julia Geppert, Jacqueline Dinnes, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 177
Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection
Catharina Gerhards, Margot Thiaucourt, Maximilian Kittel, et al.
International Journal of Infectious Diseases (2021) Vol. 107, pp. 221-227
Open Access | Times Cited: 52
HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19
Stuart Astbury, Catherine J. Reynolds, David K. Butler, et al.
Immunology (2022) Vol. 166, Iss. 1, pp. 68-77
Open Access | Times Cited: 31
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays
Gregory J. Walker, Zin Naing, Alberto Ospina Stella, et al.
Viruses (2021) Vol. 13, Iss. 2, pp. 247-247
Open Access | Times Cited: 35
Point-of-care test system for detection of immunoglobulin-G and -M against nucleocapsid protein and spike glycoprotein of SARS-CoV-2
Tao Peng, Zhiwei Sui, Zhenghui Huang, et al.
Sensors and Actuators B Chemical (2021) Vol. 331, pp. 129415-129415
Open Access | Times Cited: 30
Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk.
Ana M. Valdes, James Moon, Amrita Vijay, et al.
EClinicalMedicine (2021) Vol. 34, pp. 100835-100835
Open Access | Times Cited: 27
Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing
Verena Haselmann, Mustafa Özçürümez, Frank Klawonn, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2020) Vol. 58, Iss. 12, pp. 2121-2130
Open Access | Times Cited: 31
Antibody tests for COVID-19
Jonathan Kopel, Hemant Goyal, Abhilash Perisetti
Baylor University Medical Center Proceedings (2020) Vol. 34, Iss. 1, pp. 63-72
Open Access | Times Cited: 25
Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches
Judith A. Bouman, Julien Riou, Sebastian Bonhoeffer, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 2, pp. e1008728-e1008728
Open Access | Times Cited: 22
Comparative evaluation of SARS-CoV-2 IgG assays in India
Susmita Chaudhuri, Ramachandran Thiruvengadam, Souvick Chattopadhyay, et al.
Journal of Clinical Virology (2020) Vol. 131, pp. 104609-104609
Open Access | Times Cited: 23
A systematic review and meta-analysis of the accuracy of SARS-COV-2 IGM and IGG tests in individuals with COVID-19
Ana Cristina Lacerda Macedo, Gabriele da Silveira Prestes, Tamy Colonetti, et al.
Journal of Clinical Virology (2022) Vol. 148, pp. 105121-105121
Open Access | Times Cited: 12
A multiplex antigen microarray for simultaneous IgG and IgM detection against SARS‐CoV‐2 reveals higher seroprevalence than reported
David Ruano‐Gallego, Miriam García‐Villadangos, Mercedes Moreno‐Paz, et al.
Microbial Biotechnology (2021) Vol. 14, Iss. 3, pp. 1228-1236
Open Access | Times Cited: 16
A serological assay to detect human SARS-CoV-2 antibodies
Waleed H. Mahallawi
Journal of Taibah University Medical Sciences (2020) Vol. 16, Iss. 1, pp. 57-62
Open Access | Times Cited: 17
How can we interpret SARS-CoV-2 antibody test results?
Sofie Føns, Karen A. Krogfelt
Pathogens and Disease (2020) Vol. 79, Iss. 1
Open Access | Times Cited: 17
Comparison of Five Serological Assays for the Detection of SARS-CoV-2 Antibodies
Anja Dörschug, Julian Schwanbeck, Andreas Hahn, et al.
Diagnostics (2021) Vol. 11, Iss. 1, pp. 78-78
Open Access | Times Cited: 15
The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
Xuzhen Qin, Jun Shen, Erhei Dai, et al.
BMC Immunology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Stability of SARS-CoV-2 IgG in multiple laboratory conditions and blood sample types
Jamil N. Kanji, Ashley Bailey, Jayne Fenton, et al.
Journal of Clinical Virology (2021) Vol. 142, pp. 104933-104933
Open Access | Times Cited: 14
Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantation
Marie Luise Hütter‐Krönke, Adela Neagoie, Igor Wolfgang Blau, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Selection and characterisation of bioreceptors to develop nanoparticle-based lateral-flow immunoassays in the context of the SARS-CoV-2 outbreak
Liming Hu, Enric Calucho, Celia Fuentes‐Chust, et al.
Lab on a Chip (2022) Vol. 22, Iss. 16, pp. 2938-2943
Open Access | Times Cited: 8
Performance of Three Anti-SARS-CoV-2 Anti-S and One Anti-N Immunoassays for the Monitoring of Immune Status and Vaccine Response
Y. Victoria Zhang, Attila Kumánovics, Joesph R Wiencek, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 292-292
Open Access | Times Cited: 1
Production of antigens expressed in Nicotiana benthamiana plant and Escherichia coli for the SARS-CoV-2 IgG antibody detection by ELISA
Matheus Bernardes Torres Fogaça, Leonardo Lopes-Luz, Djairo Pastor Saavedra, et al.
Journal of Virological Methods (2024) Vol. 329, pp. 114969-114969
Closed Access | Times Cited: 1
Comparison of capillary blood self-collection using the Tasso-SST device with venous phlebotomy for anti-SARS-CoV-2 antibody measurement
Elise King, Haley E Garrett, Haley Abernathy, et al.
Journal of Immunological Methods (2023) Vol. 520, pp. 113523-113523
Open Access | Times Cited: 4
Sensitivity and specificity of 14 SARS-CoV-2 serological assays and their diagnostic potential in RT-PCR negative COVID-19 infections
Eveline Van Honacker, Liselotte Coorevits, Jerina Boelens, et al.
Acta Clinica Belgica (2020) Vol. 77, Iss. 2, pp. 315-320
Open Access | Times Cited: 10
Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay
Maximilian Kittel, Peter Findeisen, Maria-Christina Muth, et al.
International Journal of Infectious Diseases (2021) Vol. 105, pp. 632-638
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top